Summary by Moomoo AI
HuaLing Pharmaceuticals issued a notice on September 26, 2024, informing shareholders that the interim report for 2024 can now be obtained on the company's website and the Hong Kong Stock Exchange website. The company encourages shareholders to read the report and all future company communications through the website. If shareholders wish to receive a printed version of the company's communications, they can fill out the reply form and return it to ZUOJIA Securities Registration Limited by mail or email. The company also reminds shareholders to update their valid email addresses to receive company communications via email. Shareholders with any questions can call the ZUOJIA Securities Registration Limited hotline on weekdays.